HORIKAWA Masato | Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, University of Tokyo

スポンサーリンク

概要

関連著者

KATO Yukio
Department of Dental and Medical Biochemistry, Hiroshima University Graduate School of Biomedical Sc
SUGIYAMA Yuichi
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, The University of Tokyo
Kato Yukio
Department Of Applied Biological Science Tokyo University Of Science
Kato Y
Graduate School Of Pharmaceutical Sciences University Of Tokyo
HORIKAWA Masato
Graduate School of Pharmaceutical Sciences, University of Tokyo
HORIKAWA Masato
Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, University of Tokyo
Horikawa Masato
Graduate School Of Pharmaceutical Sciences University Of Tokyo
Kato Yukio
Graduate School Of Pharmaceutical Sciences University Of Tokyo
Kato Y
Department Of Dental And Medical Biochemistry Hiroshima University Graduate School Of Biomedical Sci
Sugiyama Yuichi
Graduate School Of Pharmaceutical Sciences University Of Tokyo
Sugiyama Yuichi
Department Of Applied Biological Science Faculty Of Science And Technology Science University Of Tok
Sugiyama Yuichi
Graduate School of Pharmaceutical Sciences, University of Tokyo

もっと見る

著作論文

22D-11-2 Modifying the pharmacokinetics of the anticancer drug CPT-11, and its active metabolite SN-38, aimed at reducing the biliary excretion of SN-38 and its gastrointestinal toxicity.

スポンサーリンク